로딩 중…
StockDiggingStockDigging

Penumbra, Inc.

PEN· NYSE
$323.07+0.59%
2026-08-03

Financials

Valuation Metrics

Penumbra, Inc.'s Market Cap is $12.71B. At end of 2025 it was $12.18B. Ranked #815 of 3,112 in US market (top 26%), #567 of 1,667 on NYSE (top 34%), #52 of 206 in Health Care Equipment & Services (top 25%) by Market Cap.

Investment Metrics(as of 2026-08-03)

MetricValue
Size
Market Cap$12.71B
Revenue$1.50B
Net Income$161M
Total Assets$1.97B
Net Assets$1.53B
Employees4,700
Value
P/E79.13x
P/B8.30x
P/S8.44x
EV/EBITDA60.30x
FCF Yield1.70%
Profitability
ROE10.49%
ROA8.13%
Op. Margin12.45%
Revenue Growth14.90%
Earnings Growth-23.10%
Financial Health
Debt Ratio29.00%
Total Debt$213M
FCF$216M
Cash$205M
Current Ratio5.75x
Net Debt/EBITDA0.04x
Performance
1Y Return32.95%
1M Return1.41%
From 52W High-10.86%
1Y MDD-24.20%
Trading
Volume247,910 shares
Trading Value$80M
Per Share
EPS$4.53
BPS$36.43

Company Info

CEO Mr. Adam Elsesser J.D.
Employees 4,700
HQ Alameda, United States

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX, BENCHMARK, BMX, DDC, Access25; MIDWAY, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization device, aspiration tubing, aspiration pump, and other components and accessories under the Penumbra RED, SENDit, JET, ACE, BMX, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that include the Penumbra Coil 400, for the treatment of aneurysms and other complex lesions, detachable coils of neurovascular lesions under the Penumbra SMART COIL, SwiftSET, and Penumbra SwiftPAC Coil brands; and POD400 and PAC400 brands. In addition, it provides peripheral embolization products, such as Ruby Embolization Platform, which consists of detachable coils for peripheral applications; Ruby LP and XL Embolization Platform; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; Packing Coil LP; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers neurosurgical tools comprising the Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. It sells its products through direct sales organizations and distributors. The company was incorporated in 2004 and is based in Alameda, California.